Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TAU PROTEIN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | TAU PROTEIN |
| Key Genes/Proteins | NFKB, VPS35 |
| Related Diseases | Alzheimer's Disease, Tauopathies |
graph TD
TAU_PROTEIN["TAU PROTEIN"]
style TAU_PROTEIN fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
TAU_PROTEIN -.->|"biomarker for"| Alzheimer_s_Disease["Alzheimer's Disease"]
TAU_PROTEIN -.->|"biomarker for"| Tauopathies["Tauopathies"]
TAU_PROTEIN -->|"involved_in"| Hyperphosphorylation["Hyperphosphorylation"]
TAU_PROTEIN -->|"expressed in"| Retina["/Retina/"]
TAU_PROTEIN -->|"causes"| Alzheimer_S_Disease["Alzheimer'S Disease"]
TAU_PROTEIN -->|"interacts"| NFKB([NFKB])
TAU_PROTEIN -->|"causes"| neuronal_damage["neuronal damage"]
TAU_PROTEIN -->|"activates"| Reactive_oxygen_species["Reactive oxygen species"]
Alzheimer_s_Disease -.->|"biomarker for"| TAU_PROTEIN
Cerebrospinal_Fluid["Cerebrospinal Fluid"] -->|"component_of"| TAU_PROTEIN
Post_translational_Modificatio["Post-translational Modifications"] -->|"regulates"| TAU_PROTEIN
MAPT([MAPT]) -->|"encodes"| TAU_PROTEIN
NBR1([NBR1]) -->|"interacts"| TAU_PROTEIN
CBD{"CBD"} -->|"regulates"| TAU_PROTEIN
Cannabidiol{"Cannabidiol"} -.->|"inhibits"| TAU_PROTEIN
FBXW7([FBXW7]) -->|"regulates"| TAU_PROTEIN| Target | Relation | Type | Str |
|---|---|---|---|
| Tauopathies | involved_in | disease | 0.95 |
| Neurofibrillary Tangles | causes | entity | 0.95 |
| Alzheimer's Disease | biomarker_for | disease | 0.95 |
| Hyperphosphorylation | involved_in | process | 0.95 |
| Tauopathies | biomarker_for | disease | 0.95 |
| Alzheimer'S Disease | contributes_to | disease | 0.95 |
| Alzheimer's Disease | associated_with | disease | 0.95 |
| Axonal Structure | regulates | structure | 0.92 |
| Axonal Transport | regulates | process | 0.92 |
| Retina | expressed_in | cell_type | 0.90 |
| cytoskeletal remodeling | associated_with | process | 0.90 |
| Alzheimer'S Disease | causes | disease | 0.90 |
| tau protein hyperphosphorylation | involved_in | process | 0.90 |
| CSF tau assays | biomarker_for | process | 0.88 |
| Alzheimer's Disease | causes | disease | 0.80 |
| NFKB | interacts_with | protein | 0.80 |
| RNA-binding proteins | interacts_with | protein | 0.70 |
| Oxidative Stress | interacts_with | process | 0.70 |
| Alzheimer's disease | associated_with | disease | 0.70 |
| fibrillar structures | promotes | process | 0.70 |
| Reactive oxygen species | activates | process | 0.70 |
| neurofibrillary tangles | promotes | process | 0.70 |
| RNA | interacts_with | process | 0.70 |
| cognitive dysfunction | associated_with | process | 0.70 |
| Alzheimer's disease | causes | disease | 0.70 |
| Alzheimer's disease | associated_with | disease | 0.70 |
| neurodegenerative diseases | associated_with | disease | 0.70 |
| trans-synaptic propagation | associated_with | process | 0.70 |
| neuronal damage | causes | process | 0.70 |
| Parkinson's Disease | implicated_in | disease | 0.65 |
| Aging | therapeutic_target | disease | 0.60 |
| Alzheimer | activates | disease | 0.60 |
| Als | activates | disease | 0.60 |
| Als | biomarker_for | disease | 0.60 |
| Neurodegeneration | activates | disease | 0.60 |
| Als | stabilizes | disease | 0.60 |
| Dementia | biomarker_for | disease | 0.60 |
| Dementia | stabilizes | disease | 0.60 |
| Alzheimer | protects_against | disease | 0.60 |
| Tauopathy | stabilizes | disease | 0.60 |
| Parkinson | associated_with | disease | 0.60 |
| Alzheimer | biomarker_for | disease | 0.60 |
| Neurodegeneration | causes | disease | 0.60 |
| Neuroinflammation | therapeutic_target | disease | 0.60 |
| Neuroinflammation | biomarker_for | disease | 0.60 |
| Frontotemporal Dementia | stabilizes | disease | 0.60 |
| Alzheimer | causes | disease | 0.60 |
| Aging | biomarker_for | disease | 0.60 |
| Neurodegeneration | biomarker_for | disease | 0.60 |
| Huntington | therapeutic_target | disease | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| MAPT | associated_with | gene | 0.95 |
| MAPT | associated_with | gene | 0.95 |
| 41090735 | plays pivotal roles in | paper | 0.90 |
| Hyperphosphorylation | modulates | process | 0.90 |
| VPS35 | regulates | protein | 0.85 |
| MTOR | enhances | gene | 0.80 |
| MTOR | regulates | gene | 0.80 |
| Post-translational Modifications | regulates | process | 0.80 |
| Alzheimer's disease | associated_with | disease | 0.70 |
| MAPT | encodes | gene | 0.70 |
| CBD | regulates | drug | 0.70 |
| Cannabidiol | inhibits | drug | 0.70 |
| NBR1 | regulates | protein | 0.70 |
| MTOR | activates | gene | 0.70 |
| LRP1 | regulates | gene | 0.70 |
| MAPT | encodes | gene | 0.70 |
| NBR1 | interacts_with | protein | 0.70 |
| MITOCHONDRIA | associated_with | gene | 0.60 |
| PINK1 | phosphorylates | gene | 0.60 |
| OVERVIEW | associated_with | gene | 0.60 |
| AQUAPORIN-4 | associated_with | gene | 0.60 |
| AQP4 | associated_with | gene | 0.60 |
| TAU | causes | gene | 0.60 |
| AGING | causes | gene | 0.60 |
| APOE | interacts_with | gene | 0.60 |
| APP/PS1 | activates | gene | 0.60 |
| AMYLOID | expressed_in | gene | 0.60 |
| MICROGLIA | regulates | gene | 0.60 |
| PHAGOCYTOSIS | regulates | gene | 0.60 |
| BDNF | activates | gene | 0.60 |
| APP | biomarker_for | gene | 0.60 |
| TAU | phosphorylates | gene | 0.60 |
| AMYLOID-BETA | phosphorylates | gene | 0.60 |
| TNF | activates | gene | 0.60 |
| PARKIN | phosphorylates | gene | 0.60 |
| MICROGLIA | associated_with | gene | 0.60 |
| OVERVIEW | therapeutic_target | gene | 0.60 |
| ASTROCYTES | associated_with | gene | 0.60 |
| NF-KB | therapeutic_target | gene | 0.60 |
| MICROTUBULES | interacts_with | gene | 0.60 |
| DEMENTIA | stabilizes | gene | 0.60 |
| DEMENTIA | biomarker_for | gene | 0.60 |
| DEMENTIA | causes | gene | 0.60 |
| ALZHEIMER | causes | gene | 0.60 |
| APOE | associated_with | gene | 0.60 |
| AGING | associated_with | gene | 0.60 |
| BACE1 | therapeutic_target | gene | 0.60 |
| SREBP2 | therapeutic_target | gene | 0.60 |
| ABCA1 | therapeutic_target | gene | 0.60 |
| CYP46A1 | therapeutic_target | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Pericyte senescence is sufficient to weaken the BBB even wit | 0.630 | neurodegeneration | Does pericyte senescence drive BBB break |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning TAU PROTEIN in their description or question text
No additional research found